Ofatumumab in Portuguese Multiple Sclerosis Patients - an Observational Study

Clinical trial NCT05809986 · RECRUITING

Trial details

NCT number: NCT05809986
Sponsor: Novartis Pharmaceuticals
Status: RECRUITING
Study type: OBSERVATIONAL

Relapsing Multiple Sclerosis

Start date: 2023-11-27
Primary completion: 2026-12-31
Enrollment: 174

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.